Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukaemia: a pilot study of a monocentric experience
Author(s): R. Fanci | S. Fallani | M.I. Cassetta | B. Scappini | G. Longo | M. Di Gioia | S. Bencini | A. Bosi | A. Novelli
Volume: 2
Issue: 3
Year: 2013




Allogeneic hematopoietic stem cell collection from elderly related donors: a retrospective multicenter study on mobilization and collection efficiency
Author(s): F.M. Dallavalle | S. Leoncino | P. Ferremi Leali | D. Marenchino | G. Andreola | D. Laszlo | P. Carlier | F. Ravagnani | L. Terranova | P. Perseghin | E. Sormano | T. Francisci | V. Tassi
Volume: 2
Issue: 3
Year: 2013




Tyrosin kinase inhibitors interference in fibrotic damage and immune perturbation in chronic graft versus host disease: an emerging option for patients with steroid-refractory chronic graft versus host disease
Author(s): A. Olivieri | F. Saraceni | J. Olivieri | M. Chiarucci | M. Cimminiello
Volume: 2
Issue: 3
Year: 2013




Does the reduced intensity conditioning regimen respect its promises?
Author(s): R. Angarano | I. Donnini | A. Bosi
Volume: 2
Issue: 3
Year: 2013




High-titre inhibitors in previously untreated patients with severe hemophilia A: an updated estimate of pooled incidence rates in patients treated with plasma-derived concentrates or recombinant Factor VIII
Author(s): A. Messori | V. Fadda | D. Maratea | S. Trippoli | C. Marinai
Volume: 2
Issue: 3
Year: 2013




JAK2 inhibitors and transplant in myeloproliferative neoplasms
Author(s): A.M. Vannucchi
Volume: 2
Issue: 1S
Year: 2013




Quality control of the graft in autologous transplantation
Author(s): F. Lanza | P. Spedini | D. Generali | M. Tajana | C. Fiamenghi | M. Ongari | C. Lazzari | P. Pinotti | A.L. Pasini | A. Wahlin | J. Walewski | A. Hellmann | H. Johnsen
Volume: 2
Issue: 1S
Year: 2013




Updated selection of unrelated donor
Author(s): N. Sacchi | C. Costa | F. Madia | R. Marciano | F. Vagnozzi | S. Pollichieni
Volume: 2
Issue: 1S
Year: 2013




New conditioning regimens in lymphomas
Author(s): G. Visani | P. Picardi | B. Guiducci | F. Loscocco | T. Ricciardi | S. Barulli | L. Malerba | A. Isidori
Volume: 2
Issue: 1S
Year: 2013




Stem cell mobilization in healthy donors with Plerixafor
Author(s): I. de Greef
Volume: 2
Issue: 1S
Year: 2013




Extracorporeal photopheresis guidelines GITMO/SIdEM
Author(s): L. Pierelli | A. Bosi
Volume: 2
Issue: 1S
Year: 2013




Allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: towards a personalized approach based on individual risk assessment
Author(s): J.J. Cornelissen
Volume: 2
Issue: 1S
Year: 2013




Can we afford to continue hematopoietic stem cell transplantation?
Author(s): A. Gratwohl
Volume: 2
Issue: 1S
Year: 2013




Hematopoietic stem cell transplantation in children: current practice
Author(s): S. Giardino | L.E. Radu | G. Dini
Volume: 2
Issue: 1
Year: 2013




Mobilization of hematopoietic stem cells (HSCs) for clinical transplantation
Author(s): L. Pierelli | F. Ipsevich | M. Vacca
Volume: 2
Issue: 1
Year: 2013




Treosulfan: reduced toxicity conditioning for allogeneic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
Author(s): I. Danylesko | A. Shimoni | A. Nagler
Volume: 2
Issue: 1
Year: 2013




The role of allogeneic stem cell transplantation in multiple myeloma in the new drug era
Author(s): N. Kröger
Volume: 2
Issue: 1
Year: 2013




Use of biosimilars in hematopoietic stem cells transplantation
Author(s): A. Bosi
Volume: 2
Issue: 1
Year: 2013




Monoclonal antibody therapy of adult acute lymphoblastic leukemia: progress and challenge for new clinical trials
Author(s): R. Bassan | A. M. Scattolin | E. Maino | S. Imbergamo | O. Spinelli | E. Oldani | T. Intermesoli | A. Rambaldi
Volume: 2
Issue: 1
Year: 2013




Relationship between research, academic career and scientific publications
Author(s): V. Santini
Volume: 2
Issue: 1
Year: 2013




Risk allocation of adult patients with non-M3 acute myeloid leukemia
Author(s): A. Venditti | F. Buccisano | L. Maurillo | M. I. Del Principe | C. Sarlo | A. Di Veroli | D. Nasso | C. Ditto | F. Giannotti | M. A. Grasso | A. Franchi | F. Lo-Coco | S. Amadori
Volume: 2
Issue: 1
Year: 2013




CD34+ mobilization and pbsc apheretic harvest in multiple myeloma patients at first mobilization attempt: variability in results among different centers
Author(s): G. Milone | M. Martino | S. Leotta | S. Guidi | R. Saccardi | S. Mercurio | G. Avola | M.G. Camuglia | F. Iacona | B. Bartolozzi | C. Nozzoli | A. Spadaro | S. Liggeri | S. Disca | L. Iacopino | A. Bosi
Volume: 1
Issue: 1S
Year: 2012




Allogeneic bone marrow transplantation for patients with thalassemia major
Author(s): P. Di Bartolomeo | S. Santarone | S. Angelini | P. Bavaro | E. Pennese
Volume: 1
Issue: 1S
Year: 2012




Origin and aims of the ESTM (European School of Transfusion Medicine)
Author(s): U. Rossi | A. Iacone
Volume: 1
Issue: 1S
Year: 2012




A-HPC collection: large volume or tailored procedure
Author(s): G. Crovetti | G. Martinelli
Volume: 1
Issue: 1S
Year: 2012




Transposition of standard JACIE in the laboratory of manipulation
Author(s): A. Crescimanno
Volume: 1
Issue: 1S
Year: 2012




Introduction of the JACIE standard in the PBPC collection facility
Author(s): D. Laszlo
Volume: 1
Issue: 1S
Year: 2012




Flow citometry strategies to evaluate cryopreservation efficacy
Author(s): R. Giancola | P. Accorsi | T. Bonfini | V. Catinella | A. Iacone
Volume: 1
Issue: 1S
Year: 2012




Plerixafor (Mozobil) and other mobilizing agents
Author(s): L. Pierelli | P. Perseghin
Volume: 1
Issue: 1S
Year: 2012




Gene therapy for β-thalassemia syndromes
Author(s): E. Baiamonte | R. Di Stefano | B. Spina | S. Acuto | A. Maggio
Volume: 1
Issue: 1S
Year: 2012




Update on red blood cell alloimmunization in sickle cell disease and in thalassemia
Author(s): A. Matteocci
Volume: 1
Issue: 1S
Year: 2012




ANEMO: a multidisciplinary approach for reducing patients’ exposure to allogeneic blood in orthopedic surgery
Author(s): M. Pavesi | M.B. Rondinelli | L. Pierelli | G. Inghilleri
Volume: 1
Issue: 1S
Year: 2012




Introduction of the JACIE standard in the PBPC collection facility
Author(s): D. Laszlo
Volume: 1
Issue: 1
Year: 2012




Allogeneic bone marrow transplantation for patients with thalassemia major
Author(s): P. Di Bartolomeo | S. Santarone | S. Angelini | P. Bavaro | E. Pennese
Volume: 1
Issue: 1
Year: 2012




Transposition of standard JACIE in the laboratory of manipulation
Author(s): A. Crescimanno
Volume: 1
Issue: 1
Year: 2012




Flow citometry strategies to evaluate cryopreservation efficacy
Author(s): R. Giancola | P. Accorsi | T. Bonfini | V. Catinella | A. Iacone
Volume: 1
Issue: 1
Year: 2012




Plerixafor (Mozobil) and other mobilizing agents
Author(s): L. Pierelli | P. Perseghin
Volume: 1
Issue: 1
Year: 2012




CD34+ mobilization and pbsc apheretic harvest in multiple myeloma patients at first mobilization attempt: variability in results among different centers
Author(s): G. Milone | M. Martino | S. Leotta | S. Guidi | R. Saccardi | S. Mercurio | G. Avola | M.G. Camuglia | F. Iacona | B. Bartolozzi | C. Nozzoli | A. Spadaro | S. Liggeri | S. Disca | L. Iacopino | A. Bosi
Volume: 1
Issue: 1
Year: 2012




ANEMO: a multidisciplinary approach for reducing patients’ exposure to allogeneic blood in orthopedic surgery
Author(s): M. Pavesi | M.B. Rondinelli | L. Pierelli | G. Inghilleri
Volume: 1
Issue: 1
Year: 2012




Origin and aims of the ESTM (European School of Transfusion Medicine)
Author(s): U. Rossi | A. Iacone
Volume: 1
Issue: 1
Year: 2012




A-HPC collection: large volume or tailored procedure
Author(s): G. Crovetti | G. Martinelli
Volume: 1
Issue: 1
Year: 2012




Gene therapy for β-thalassemia syndromes
Author(s): E. Baiamonte | R. Di Stefano | B. Spina | S. Acuto | A. Maggio
Volume: 1
Issue: 1
Year: 2012




Update on red blood cell alloimmunization in sickle cell disease and in thalassemia
Author(s): A. Matteocci
Volume: 1
Issue: 1
Year: 2012



